Trial Profile
Granulocyte-Macrophage Stimulating Factor (GM-CSF) and Mobilization of Progenitor Cells in Peripheral Arterial Disease: A Phase II Randomized Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Sargramostim (Primary)
- Indications Peripheral arterial disorders
- Focus Therapeutic Use
- 09 Sep 2015 New trial record